Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by polyethylene glycol on anticancer drug-induced neutropenia in mice
- 31 May 1994
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 25 (3) , 533-537
- https://doi.org/10.1016/0306-3623(94)90211-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Chemical Modification of Recombinant Human Granulocyte Colony-Stimulating Factor by Polyethylene Glycol Increases its Biological Activity in vivo.Cell Structure and Function, 1992
- Recombinant Granulocyte Colony-Stimulating Factor (rG-CSF)Drugs, 1991
- Neutrophil kinetics of recombinant human granulocyte colony-stimulating factor-induced neutropenia in ratsLife Sciences, 1989
- Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factorBlood, 1989
- Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid CellsScience, 1986
- The molecular biology and functions of the granulocyte-macrophage colony-stimulating factorsBlood, 1986
- Pharmacokinetic properties of polyethylene glycol derivatized superoxide dismutasePharmacological Research Communications, 1982
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976